Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
CEO: Alton E. Shader. Company website
Sotera Health Company (SHC) trades at $18.73, down 1.16% on the day, as of Sep 20, 2026 14:57 UTC.
Sotera Health Company has a market capitalisation of $5.34B, calculated from the live SHC share price and shares outstanding.
SHC trades at a trailing P/E of 32.86, from earnings per share of $0.57 over the last twelve months.
Sotera Health Company generated revenue of $1.22B over the trailing twelve months, which puts the stock at 4.39 times sales.
SHC has traded between $13.09 and $19.85 over the past 52 weeks, and the last price is 5.6% below that high.
Yes. Sotera Health Company keeps 13.44% of revenue as net income over the trailing twelve months.
Wall Street analysts rate SHC Buy, with an average price target of $20.50, 9.5% above the current price.
Sotera Health Company is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US.
Alton E. Shader is the chief executive of Sotera Health Company, which employs 3,000 people.
QFI Terminal shows SHC with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open SHC in Terminal See plans